Biodyne Statistics
Total Valuation
Biodyne has a market cap or net worth of KRW 361.04 billion. The enterprise value is 340.34 billion.
Market Cap | 361.04B |
Enterprise Value | 340.34B |
Important Dates
The last earnings date was Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biodyne has 29.76 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 29.76M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 46.56% |
Owned by Institutions (%) | 1.10% |
Float | 15.91M |
Valuation Ratios
The trailing PE ratio is 33,522.40 and the forward PE ratio is 88.54.
PE Ratio | 33,522.40 |
Forward PE | 88.54 |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 9.06 |
P/FCF Ratio | 1,067.33 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 31,600.28 |
EV / Sales | 64.56 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 1,006.13 |
Financial Position
The company has a current ratio of 19.48, with a Debt / Equity ratio of 0.00.
Current Ratio | 19.48 |
Quick Ratio | 18.96 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | 0.04 |
Interest Coverage | -9,941.41 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on invested capital (ROIC) is -2.50%.
Return on Equity (ROE) | 0.02% |
Return on Assets (ROA) | -2.45% |
Return on Invested Capital (ROIC) | -2.50% |
Return on Capital Employed (ROCE) | -4.00% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.12 |
Inventory Turnover | 6.51 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.97% in the last 52 weeks. The beta is 1.83, so Biodyne's price volatility has been higher than the market average.
Beta (5Y) | 1.83 |
52-Week Price Change | +30.97% |
50-Day Moving Average | 13,977.40 |
200-Day Moving Average | 15,835.90 |
Relative Strength Index (RSI) | 33.72 |
Average Volume (20 Days) | 314,305 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodyne had revenue of KRW 5.27 billion and earned 10.77 million in profits.
Revenue | 5.27B |
Gross Profit | 2.44B |
Operating Income | -1.73B |
Pretax Income | -141.10M |
Net Income | 10.77M |
EBITDA | -107.90M |
EBIT | -1.73B |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 20.71 billion in cash and 12.07 million in debt, giving a net cash position of 20.70 billion or 695.52 per share.
Cash & Cash Equivalents | 20.71B |
Total Debt | 12.07M |
Net Cash | 20.70B |
Net Cash Per Share | 695.52 |
Equity (Book Value) | 43.20B |
Book Value Per Share | n/a |
Working Capital | 21.21B |
Cash Flow
In the last 12 months, operating cash flow was 877.41 million and capital expenditures -539.15 million, giving a free cash flow of 338.26 million.
Operating Cash Flow | 877.41M |
Capital Expenditures | -539.15M |
Free Cash Flow | 338.26M |
FCF Per Share | 11.36 |
Margins
Gross margin is 46.25%, with operating and profit margins of -32.82% and 0.20%.
Gross Margin | 46.25% |
Operating Margin | -32.82% |
Pretax Margin | -2.68% |
Profit Margin | 0.20% |
EBITDA Margin | -2.05% |
EBIT Margin | -32.82% |
FCF Margin | 6.42% |
Dividends & Yields
Biodyne does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 0.00% |
FCF Yield | 0.09% |
Stock Splits
The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.
Last Split Date | Feb 28, 2024 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Biodyne has an Altman Z-Score of 217.67.
Altman Z-Score | 217.67 |
Piotroski F-Score | n/a |